Mood Disorders News

Individuals who received Botox injections were significantly less likely to report depression vs. those who received different treatments, according to study results published in Scientific Reports.

The COVID-19 pandemic lockdown appeared associated with a significant reduction in individuals’ mood homeostasis, according to results of a cohort study published in JAMA Psychiatry.

Vortioxetine appeared to reduce cognitive impairment among patients with major depressive disorder, according to results of a systematic review published in Journal of Clinical Psychiatry.

Area-level artificial light at night, or ALAN, may negatively affect sleep patterns and increase risk for mood and anxiety disorders among adolescents, according to results of a study published in JAMA Psychiatry.

Patients with major depressive disorder and comorbid PTSD who were unresponsive to antidepressant treatment exhibited a positive response to three “next-step” treatments, according to a study published in Journal of Clinical Psychiatry.

In 2008, the U.S. House of Representatives designated July as Bebe Moore Campbell National Minority Mental Health Awareness Month.

Individuals with depression who experienced loss of interest and reduced activity appeared to benefit more from aripiprazole augmentation than escitalopram monotherapy, according to findings published in Journal of Clinical Psychiatry.

Antidepressants augmented with intranasal esketamine appeared effective among patients with major depressive disorder who were treatment-resistant or acutely suicidal, according to study results published in Journal of Clinical Psychiatry.

Adjunctive ganaxolone appeared to reduce persistent depression among postmenopausal women, according to results of an open-label, uncontrolled pilot study published in Journal of Clinical Psychiatry.

Healio Psychiatry has compiled a list of its top five viewed stories in June.